Skip to content

Neutrophil to Lymphocyte Ratio as A Marker in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy in HRH Princess Maha Chakri Sirindhorn Medical Center

Neutrophil to Lymphocyte Ratio as A Marker in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy in HRH Princess Maha Chakri Sirindhorn Medical Center:retrospective crossectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20210506003
Enrollment
90
Registered
2021-05-06
Start date
2005-01-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neutrophil to lypmphocte ratio in Non-arteritic Anterior Ischemic Optic Neuropathy neutrophil to lymphocyte ratio, Non-arteritic Anterior Ischemic Optic Neuropathy

Interventions

Group one was those who were diagnosed with NAION which were fit the Inclusion criteria 1. Acute painless visual loss 2. Presence of relative afferent pupillary defect 3. Visual field defect which is
Other,Other,Other
NAION patients,cataract with underlying diseases patients,cataract without underlying disease patients

Sponsors

HRH Princess Mahachakri Sirindhorn Medical Center, Facalty of Medicine, Srinakharinwirot University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Acute painless visual loss 2. Presence of relative afferent pupillary defect 3. Visual field defect which is compatible with disease 4. Optic nerve head change that is consistent with disease 5. No other abnormal ophthalmic findings that can mimic other ophthalmic disease

Exclusion criteria

Exclusion criteria: 1. Subjects with underlying disease effected a blood test result e.g. inflammatory diseases, leukemia, thrombocytosis, and Multiple myeloma 2. History of smoking and alcohol drinking 3. Retinal diseases e.g. diabetic retinopathy, retinal vein occlusion and hypertensive retinopathy 4. Glaucoma diseases 5. Other Neuro-opthalmic diseases 6.the patient who received any kind of treatment for NAION

Design outcomes

Primary

MeasureTime frame
neutrophil lymphocyte ratio at first examination in NAION group and at pre operative evaluation day in the other two groups complete blood count

Secondary

MeasureTime frame
visual acuity (VA) First time examination, 3 months follow up snellen chart

Countries

Thailand

Contacts

Public ContactPannaluck Sinsawad

Srinakharinwirot University

pannaluck_oph@hotmail.com037395258

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026